Login / Signup

Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.

Yunha NamHo Cheol KimYoung-Chul KimSeung Hun JangKye Young LeeShin-Yup LeeSang Hoon LeeSung Yong LeeSeong Hoon YoonJeong-Seon RyuTae Won JangYoon Soo ChangSeung Joon KimChan Kwon ParkJeong Eun LeeChi Young JungChang-Min Choi
Published in: Thoracic cancer (2021)
Rebiopsy might affect the clinical course of patients with EGFR-mutant adenocarcinoma who receive EGFR-TKIs.
Keyphrases
  • epidermal growth factor receptor
  • tyrosine kinase
  • advanced non small cell lung cancer
  • wild type
  • squamous cell carcinoma
  • small cell lung cancer